ArticleScientific reports2025

Cost-effectiveness of hypofractionated radiation therapy versus conventional radiation therapy for unresectable stage III non-small cell lung cancer.

Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.